SE8404707L - Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav - Google Patents

Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Info

Publication number
SE8404707L
SE8404707L SE8404707A SE8404707A SE8404707L SE 8404707 L SE8404707 L SE 8404707L SE 8404707 A SE8404707 A SE 8404707A SE 8404707 A SE8404707 A SE 8404707A SE 8404707 L SE8404707 L SE 8404707L
Authority
SE
Sweden
Prior art keywords
extract
insulated
composition containing
detoxified endotoxin
containing pyridine
Prior art date
Application number
SE8404707A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404707D0 (sv
Inventor
J L Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of SE8404707D0 publication Critical patent/SE8404707D0/xx
Publication of SE8404707L publication Critical patent/SE8404707L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8404707A 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav SE8404707L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
SE8404707D0 SE8404707D0 (sv) 1984-09-20
SE8404707L true SE8404707L (sv) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404707A SE8404707L (sv) 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Country Status (23)

Country Link
US (1) US4663306A (fr)
JP (1) JPS60120817A (fr)
KR (1) KR870000843B1 (fr)
AT (1) AT385659B (fr)
AU (1) AU566234B2 (fr)
BE (1) BE900650A (fr)
CA (1) CA1244765A (fr)
CH (1) CH664897A5 (fr)
DE (1) DE3434766A1 (fr)
DK (1) DK446684A (fr)
ES (1) ES8608872A1 (fr)
FI (1) FI843716L (fr)
FR (1) FR2552326B1 (fr)
GB (1) GB2149301B (fr)
HU (1) HU192585B (fr)
IL (1) IL73034A (fr)
IN (1) IN157240B (fr)
IT (1) IT1179444B (fr)
NL (1) NL8402902A (fr)
NO (1) NO843776L (fr)
NZ (1) NZ209635A (fr)
SE (1) SE8404707L (fr)
ZA (1) ZA847405B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
EP0714305B1 (fr) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Composition et procede servant a stimuler les capacites de reproduction
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
US6329347B1 (en) 1997-08-05 2001-12-11 Bioniche Life Sciences Inc. Composition and method for the treatment of bladder cancer
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
JP4447779B2 (ja) * 1998-07-16 2010-04-07 市郎 東 細菌の菌体成分を有効成分とする癌免疫療法用製剤
WO2001044465A2 (fr) * 1999-12-13 2001-06-21 Bioniche Life Sciences Inc. Oligonucleotides synthetiques utiles du point de vue therapeutique
AU784356B2 (en) * 1999-12-28 2006-03-16 Bioniche Urology Ip Inc. Hyaluronic acid in the treatment of cancer
WO2002004019A2 (fr) * 2000-07-11 2002-01-17 Bayer Aktiengesellschaft Utilisation de souches du virus parapox ovis contre la fibrose des organes
US20050106155A1 (en) * 2002-03-05 2005-05-19 Tadao Ohno Solidified tissue immuoadjuvant
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CN106661543A (zh) 2014-06-17 2017-05-10 Xycrobe治疗公司 经遗传修饰的细菌和用于细菌的遗传修饰的方法
WO2017147507A1 (fr) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Formulation probiotique à usage cutané

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (fr) * 1972-06-20 1973-12-27
FR2269962B1 (fr) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1209504A (fr) * 1982-06-30 1986-08-12 John L. Cantrell Extrait de microorganisme soluble dans la pyridine
CA1206416A (fr) * 1982-06-30 1986-06-24 John L. Cantrell Extrait de pyridine soluble provenant de microorganismes
CA1206415A (fr) * 1982-06-30 1986-06-24 John L. Cantrell Extrait de pyridine soluble provenant de microorganismes

Also Published As

Publication number Publication date
KR850002404A (ko) 1985-05-13
CA1244765A (fr) 1988-11-15
SE8404707D0 (sv) 1984-09-20
GB2149301A (en) 1985-06-12
ES8608872A1 (es) 1986-07-16
NZ209635A (en) 1989-01-27
JPS60120817A (ja) 1985-06-28
AU3340084A (en) 1985-03-28
FI843716L (fi) 1985-03-24
IT1179444B (it) 1987-09-16
DK446684D0 (da) 1984-09-19
HU192585B (en) 1987-06-29
BE900650A (fr) 1985-03-21
NL8402902A (nl) 1985-04-16
IN157240B (fr) 1986-02-15
AU566234B2 (en) 1987-10-15
DE3434766C2 (fr) 1987-05-14
FR2552326B1 (fr) 1988-05-13
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
US4663306A (en) 1987-05-05
ATA302384A (de) 1987-10-15
GB2149301B (en) 1988-06-22
IL73034A (en) 1988-11-15
CH664897A5 (de) 1988-04-15
AT385659B (de) 1988-05-10
IT8448894A0 (it) 1984-09-24
DE3434766A1 (de) 1986-04-30
FR2552326A1 (fr) 1985-03-29
ES536167A0 (es) 1986-07-16
NO843776L (no) 1985-03-25
GB8423993D0 (en) 1984-10-31
DK446684A (da) 1985-03-24
JPS6254775B2 (fr) 1987-11-17
KR870000843B1 (ko) 1987-04-25
HUT35521A (en) 1985-07-29

Similar Documents

Publication Publication Date Title
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
BE893803A (fr) Schoen voor atleten
DK173883D0 (da) Substituerede 8-phenylxanthiner
IT7968973A0 (it) Trinciatrice per la distruzione di documenti
BE892674A (fr) Destructeur de microfilms
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
NO834408L (no) Neisseria gonorrhoeae-vaksine
FR2550945B1 (fr) Compositions d'endotoxines purifiees et leur application pharmacologique
DE3750642D1 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene.
ATE11410T1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-on.
NL194960B (nl) Werkwijze voor het bereiden van mutantstammen van Bordetella bronchiseptica en daarop gebaseerd levend verzwakt vaccin.
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
BE880885A (fr) Composition therapeutique antithrombotique
NL7902162A (nl) Voorversterkers voor kleurentelevisiekamera's.
IT8125642A0 (it) Procedimento per la duplicazione di sagome e finiture.
IT1120568B (it) Trappola per topi e simili
IT1119156B (it) Procedimento per la preparazione di 2 alcossi 4 6 dicloro s triazine
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
FR2511599B1 (fr) Vaccin anticoquelucheux
KR880010391U (ko) 한글문서작성 채점판
IT7804236V0 (it) Congiunzione di pannelli per mobili e simili.
ES510096A0 (es) "procedimiento para la decoracion de vidrios y cristales".
DK545883A (da) Neisseria gonorrhoeae vaccine
ES234537Y (es) Disposicion de vitrina expositora.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8404707-5

Effective date: 19900401